Patterns of hypertension management in France in 2015: The ESTEBAN survey.
adherence
awareness
control
hypertension
therapy
Journal
Journal of clinical hypertension (Greenwich, Conn.)
ISSN: 1751-7176
Titre abrégé: J Clin Hypertens (Greenwich)
Pays: United States
ID NLM: 100888554
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
19
11
2019
revised:
21
01
2020
accepted:
06
02
2020
pubmed:
25
2
2020
medline:
20
5
2021
entrez:
25
2
2020
Statut:
ppublish
Résumé
The purposes of this study were to describe the hypertensive population and therapeutic management of hypertension in adults between 18 and 74 years of age in France in 2015. Esteban survey is a cross-sectional survey with a clinical examination conducted in a representative sample of French adults aged 18-74 years between 2014 and 2016. Esteban was entirely public-funded. Blood pressure (BP) was measured during clinical examination with a standardized protocol, and pharmacological treatment was collected through the exhaustive Système National des Données de Santé (SNDS) database. Hypertension was defined by systolic BP (SBP)> 140 mm Hg, diastolic BP (DBP)> 90 mm Hg or treatment with BP-lowering drugs. The therapeutic control of treated hypertensive patients was defined by SBP < 140 mm Hg and DBP < 90 mm Hg. Adherence to drug treatment was defined as more than 80% of days covered by BP-lowering drug per year. The prevalence of hypertension was 31.3%. 74.7% of aware hypertensive participants taking an antihypertensive drug, and 57.7% of them were treated with a single antihypertensive pharmacological class. Overall, among hypertensives, 24.3% had a satisfactory BP control. Only 49.7% of treated hypertensives participants were controlled, and 33.6% of them were adherent to their drug treatment. The prevalence of hypertension in France remains high, with only 74.7% of the aware hypertensive participants receiving pharmacological therapy and only 48.9% of aware hypertensives with a BP at goal. More effective measures are needed to improve clinical management of hypertension in France.
Identifiants
pubmed: 32092238
doi: 10.1111/jch.13834
pmc: PMC8029843
doi:
Substances chimiques
Antihypertensive Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
663-672Informations de copyright
© 2020 Wiley Periodicals, Inc.
Références
Rev Epidemiol Sante Publique. 2017 Oct;65 Suppl 4:S149-S167
pubmed: 28756037
MMWR Morb Mortal Wkly Rep. 2018 Feb 23;67(7):219-224
pubmed: 29470459
J Clin Hypertens (Greenwich). 2008 Aug;10(8):644-6
pubmed: 18772648
J Fam Pract. 1994 Feb;38(2):166-71
pubmed: 8308509
Eur J Prev Cardiol. 2012 Apr;19(2):213-20
pubmed: 21450611
Lancet. 2019 Aug 24;394(10199):639-651
pubmed: 31327564
Am Heart J. 2005 May;149(5):785-94
pubmed: 15894958
Am J Med Sci. 2014 Aug;348(2):139-45
pubmed: 24978148
Lancet. 2017 Jan 7;389(10064):37-55
pubmed: 27863813
NCHS Data Brief. 2015 Nov;(220):1-8
pubmed: 26633197
J Hum Hypertens. 2015 Apr;29(4):247-53
pubmed: 25273858
J Clin Hypertens (Greenwich). 2020 Apr;22(4):663-672
pubmed: 32092238
Curr Hypertens Rep. 2015 Dec;17(12):94
pubmed: 26560139
Soc Sci Med. 2000 May;50(10):1385-401
pubmed: 10741575
Hypertens Res. 2015 Jan;38(1):1-7
pubmed: 25319601
Am J Hypertens. 2008 Jul;21(7):789-98
pubmed: 18451806
Lancet. 2005 Jan 15-21;365(9455):217-23
pubmed: 15652604
J Clin Hypertens (Greenwich). 2008 Apr;10(4):311-6
pubmed: 18401229
Lancet. 2014 May 31;383(9932):1912-9
pubmed: 24881995
J Hypertens. 2013 Jul;31(7):1281-357
pubmed: 23817082
Health Rep. 2019 Feb 20;30(2):14-21
pubmed: 30785635
Front Pharmacol. 2018 Nov 20;9:1290
pubmed: 30524276
Hypertension. 2011 Nov;58(5):804-10
pubmed: 21968751
JAMA. 2013 Sep 4;310(9):959-68
pubmed: 24002282
Annu Rev Public Health. 2015 Mar 18;36:109-30
pubmed: 25594330
AMIA Annu Symp Proc. 2006;:494-8
pubmed: 17238390
Fundam Clin Pharmacol. 2014 Feb;28(1):1-9
pubmed: 23952903
Eur Heart J. 2016 Mar 14;37(11):908-916
pubmed: 26643266
Circ Cardiovasc Qual Outcomes. 2012 May;5(3):343-51
pubmed: 22550130
Hypertension. 2018 Jun;71(6):1269-1324
pubmed: 29133354
Nat Rev Cardiol. 2011 Aug 09;8(12):686-93
pubmed: 21826071
Vital Health Stat 13. 2001 Jul;(149):1-46
pubmed: 11478128
Ann Cardiol Angeiol (Paris). 2013 Jun;62(3):132-8
pubmed: 23743000
J Hypertens. 2011 Mar;29(3):610-8
pubmed: 21157368
J Hypertens. 2014 Jun;32(6):1211-21
pubmed: 24675681
Lancet. 2008 May 3;371(9623):1513-8
pubmed: 18456100
Eur J Epidemiol. 2004;19(1):25-32
pubmed: 15012019